Uncommon Cents Investing LLC Has $660,000 Stake in Solventum Corporation $SOLV

Uncommon Cents Investing LLC lowered its stake in shares of Solventum Corporation (NYSE:SOLV) by 3.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,709 shares of the company’s stock after selling 279 shares during the quarter. Uncommon Cents Investing LLC’s holdings in Solventum were worth $660,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Rossby Financial LCC bought a new stake in shares of Solventum during the 1st quarter valued at $25,000. Strengthening Families & Communities LLC raised its stake in Solventum by 376.8% in the first quarter. Strengthening Families & Communities LLC now owns 329 shares of the company’s stock valued at $25,000 after purchasing an additional 260 shares in the last quarter. Hara Capital LLC acquired a new position in Solventum in the first quarter valued at about $38,000. Smartleaf Asset Management LLC lifted its position in Solventum by 193.4% during the first quarter. Smartleaf Asset Management LLC now owns 534 shares of the company’s stock worth $40,000 after purchasing an additional 352 shares during the period. Finally, Costello Asset Management INC acquired a new stake in Solventum during the first quarter worth about $42,000.

Solventum Stock Performance

Shares of Solventum stock opened at $71.43 on Friday. The stock has a market cap of $12.38 billion, a price-to-earnings ratio of 33.07, a P/E/G ratio of 2.90 and a beta of 0.53. Solventum Corporation has a twelve month low of $60.70 and a twelve month high of $85.92. The company’s fifty day moving average is $72.84 and its 200 day moving average is $72.23. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.14.

Solventum (NYSE:SOLV) last posted its quarterly earnings results on Thursday, August 7th. The company reported $1.69 EPS for the quarter, topping analysts’ consensus estimates of $1.45 by $0.24. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The business had revenue of $2.16 billion during the quarter, compared to analysts’ expectations of $2.12 billion. During the same period last year, the company posted $1.56 earnings per share. The business’s quarterly revenue was up 3.8% on a year-over-year basis. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. Sell-side analysts forecast that Solventum Corporation will post 6.58 EPS for the current year.

Analyst Ratings Changes

Several analysts recently issued reports on SOLV shares. Piper Sandler reiterated an “overweight” rating and set a $94.00 price target (up previously from $87.00) on shares of Solventum in a research report on Friday, August 8th. Wells Fargo & Company raised their target price on Solventum from $79.00 to $82.00 and gave the company an “equal weight” rating in a report on Monday, September 15th. Argus upgraded Solventum from a “hold” rating to a “buy” rating and set a $90.00 price target on the stock in a research note on Tuesday, July 1st. KeyCorp started coverage on Solventum in a research report on Friday, June 6th. They set a “sector weight” rating for the company. Finally, Wall Street Zen cut Solventum from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, September 9th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Solventum presently has a consensus rating of “Hold” and a consensus price target of $85.44.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.